Top Biotech Stocks to Watch in May 2025

Alan Clearwater · May 1, 2025 4:15 AM

Biotech stocks are heating up in May 2025, with breakthroughs in gene therapies, oncology, and rare disease treatments driving investor excitement.

Intro Summary
Here’s a look at the top biotech stocks on Wall Street’s radar this month.

Top Picks
• Regulus Therapeutics (RGLS) — promising results in RNA therapies
• Vertex Pharmaceuticals (VRTX) — strong pipeline in cystic fibrosis
• Moderna (MRNA) — advancing mRNA vaccines beyond COVID
• CRISPR Therapeutics (CRSP) — leading gene editing innovations
• Gilead Sciences (GILD) — expanding its oncology portfolio

“Biotech’s innovation cycle is in full swing, and companies with late-stage assets are particularly well-positioned,” said Dr. Elaine Park, healthcare strategist at BioEdge Partners.

Why It Matters

• The biotech sector has rebounded from a tough 2024

• Investors are focusing on late-stage clinical successes

• M&A activity is heating up among mid-cap biotech players

Analyst Take
While volatility remains high, analysts see strong upside for companies with clear catalysts.

“These aren’t speculative plays; they have real clinical momentum,” said Mark Jensen, biotech analyst at Medline Equity.

Conclusion
Biotech stocks remain a compelling part of the growth portfolio for investors willing to ride out the ups and downs.

Disclaimer
This article is for informational purposes only and does not constitute investment advice.